DISPOSITION IN NORMAL VOLUNTEERS OF SODIUM AZODISALICYLATE, A POTENTIAL THERAPEUTIC AGENT IN INFLAMMATORY BOWEL-DISEASE

DISPOSITION IN NORMAL VOLUNTEERS OF SODIUM AZODISALICYLATE, A POTENTIAL THERAPEUTIC AGENT IN INFLAMMATORY BOWEL-DISEASE

書誌詳細
主要な著者:	Willoughby, C, Aronson, J, Agback, H, Bodin, N, Andersson, E, Truelove, S
フォーマット:	Journal article
言語:	English
出版事項:	1981

類似資料

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.
著者:: Willoughby, C, 等
出版事項: (1982)

Disodium azodisalicylate in ulcerative colitis.
著者:: Jewell, D, 等
出版事項: (1981)

THE DISPOSITION AND METABOLISM OF SULPHASALAZINE (SALICYLAZOSULFAPYRIDINE) IN MAN
著者:: Khan, A, 等
出版事項: (1982)

Drugs as causative agents and therapeutic agents in inflammatory bowel disease
著者:: Phani Krishna Kondamudi, 等
出版事項: (2013-09-01)

The effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers.
著者:: Moraes, M, 等
出版事項: (1991)

Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases
著者:: Irene Mignini, 等
出版事項: (2023-12-01)

Therapeutic efficacy of jeoryeong-tang in dextran sulfate sodium-induced mouse model of inflammatory bowel disease
著者:: Il-Woong Jang, 等
出版事項: (2025-01-01)

Therapeutic targets in inflammatory bowel disease
著者:: Daniela Fluxa, 等
出版事項: (2019-07-01)

Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents
著者:: Orazio Palmieri, 等
出版事項: (2024-06-01)

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
著者:: Chang Soo Eun
出版事項: (2017-01-01)

Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
著者:: Katie Lloyd, 等
出版事項: (2020-11-01)

Bicervical Normal Uterus with Normal Vagina and Anteroposterior Disposition of the Double Cervix
著者:: José Morales-Roselló, 等
出版事項: (2011-01-01)

The discovery of the foxglove as a therapeutic agent
著者:: Aronson, J
出版事項: (1987)

Therapeutic Drug Monitoring in Inflammatory Bowel Disease
著者:: Manoel Alvaro de Freitas Lins Neto, 等
出版事項: (2023-12-01)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
著者:: Marafini I, 等
出版事項: (2020-06-01)

Evolving Therapeutic Strategies in the Inflammatory Bowel Disease
著者:: Soo-Young Na, 等
出版事項: (2018-02-01)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
著者:: Fei-Yan Fan, 等
出版事項: (2017-03-01)

Sodium phosphate solution as bowel preparation for outpatient diagnostic and therapeutic manipulations
著者:: N. V. Topchy, 等
出版事項: (2017-12-01)

Advances in biological agents in the treatment of inflammatory bowel disease
著者:: Na LI, 等
出版事項: (2022-08-01)

The Role of Biologics Agent in the Treatment of Inflammatory Bowel Disease
著者:: Tri Hapsoro Guno, 等
出版事項: (2017-12-01)

Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis
著者:: Bufu Tang, 等
出版事項: (2020-11-01)

Neurochemical studies in normal volunteers
著者:: Nutt, D, 等
出版事項: (1988)

Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases
著者:: Broering MF, 等
出版事項: (2024-04-01)

Translating immunology into therapeutic concepts for inflammatory bowel disease
著者:: Uhlig, HH, 等
出版事項: (2018)

Genetically engineered bacteria as inflammatory bowel disease therapeutics
著者:: Zhen-Ping Zou, 等
出版事項: (2024-12-01)

Ferroptosis: A therapeutic opportunity of inflammatory bowel disease
著者:: Yulin Ye, 等
出版事項: (2024-04-01)

Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease
著者:: Sung Noh Hong
出版事項: (2017-09-01)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
著者:: Qiuyun Xu, 等
出版事項: (2021-03-01)

Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases
著者:: Giovanni Pallio
出版事項: (2023-09-01)

Gut microbiome–based therapeutics in inflammatory bowel disease
著者:: Kelly A. Hu, 等
出版事項: (2023-04-01)

Nutritional approach as therapeutic manipulation in inflammatory bowel disease
著者:: Jin Young Yoon
出版事項: (2019-10-01)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
著者:: Tao Zuo, 等
出版事項: (2018-09-01)

The microbiota in inflammatory bowel disease: current and therapeutic insights
著者:: Lane ER, 等
出版事項: (2017-06-01)

THE DISPOSITION OF ORAL RUBIDIUM CHLORIDE IN ESSENTIAL-HYPERTENSION
著者:: Boon, N, 等
出版事項: (1982)

The dispositional effects of holidays on investor sentiment: Therapeutic and hygienic
著者:: Qing Liu, 等
出版事項: (2023-04-01)

CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers
著者:: Abdullahi, ST, 等
出版事項: (2019)

Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics
著者:: Jürgen B. Bulitta, 等
出版事項: (2019-07-01)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
著者:: Aronson, J, 等
出版事項: (1982)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
著者:: Al Sulais E, 等
出版事項: (2020-01-01)

Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease.
著者:: Mahida, Y, 等
出版事項: (1989)